论文部分内容阅读
我国药品行业逐步由纯粹的福利事业过渡到以市场为导向配置资源的状况,加入WTO有利于推动我国药品行业的改革与发展。 正面影响: 1、部分制药企业会有更大的优势 那些拥有自主知识产权能发新产品的厂商不仅在国内市场上不会受到冲击,而且能以更优惠的条件出口。另外,对于拥有质量和价格在市场上都属于一流且产品出口量大的药品公司也存在发展的良机。 2、制药企业进步会加快 一方面国内企业间竞争推动了企业的技术创新,另一方面国外技术输入迫使中国企业技术进步速度加快。医药企业两极分化、优胜劣汰的调整阶段进程加快。规模
China’s pharmaceutical industry has gradually transitioned from a purely welfare business to a market-oriented one. The accession to the WTO will help promote the reform and development of the pharmaceutical industry in China. Positive impact: 1. Some pharmaceutical companies will have greater advantages Those manufacturers with independent intellectual property rights who can send new products will not only be impacted in the domestic market, but also be able to export on more favorable conditions. In addition, there is also a good opportunity for the development of pharmaceutical companies that have quality and price in the market that are both first class and have large export volumes. 2. The progress of pharmaceutical companies will accelerate. On the one hand, competition among domestic enterprises has promoted technological innovation of enterprises. On the other hand, foreign technology input has forced Chinese enterprises to accelerate technological progress. The adjustment process of pharmaceutical companies’ polarization and the survival of the fittest has accelerated. scale